Cubist Systematic Strategies’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,020
| Closed | -$591K | – | 4178 |
|
|
2023
Q2 | $591K | Sell |
14,020
-206,017
| -94% | -$8.33M | ﹤0.01% | 2291 |
|
|
2023
Q1 | $7.84M | Sell |
220,037
-14,476
| -6% | -$525K | 0.05% | 598 |
|
|
2022
Q4 | $8.6M | Sell |
234,513
-13,555
| -5% | -$536K | 0.05% | 588 |
|
|
2022
Q3 | $11.7M | Buy |
248,068
+142,982
| +136% | +$9.24M | 0.07% | 383 |
|
|
2022
Q2 | $7.53M | Buy |
105,086
+56,310
| +115% | +$4.12M | 0.05% | 648 |
|
|
2022
Q1 | $3.95M | Buy |
48,776
+37,513
| +333% | +$3.17M | 0.03% | 915 |
|
|
2021
Q4 | $1.16M | Sell |
11,263
-19,650
| -64% | -$1.89M | 0.01% | 1811 |
|
|
2021
Q3 | $2.7M | Sell |
30,913
-18,081
| -37% | -$1.64M | 0.03% | 820 |
|
|
2021
Q2 | $4.38M | Buy |
48,994
+14,554
| +42% | +$1.23M | 0.05% | 619 |
|
|
2021
Q1 | $2.61M | Sell |
34,440
-7,029
| -17% | -$530K | 0.03% | 858 |
|
|
2020
Q4 | $2.83M | Sell |
41,469
-10,745
| -21% | -$670K | 0.04% | 750 |
|
|
2020
Q3 | $2.78M | Buy |
52,214
+16,646
| +47% | +$991K | 0.04% | 709 |
|
|
2020
Q2 | $2.07M | Buy |
35,568
+8,692
| +32% | +$467K | 0.04% | 773 |
|
|
2020
Q1 | $1.06M | Buy |
26,876
+17,851
| +198% | +$1.04M | 0.03% | 791 |
|
|
2019
Q4 | $537K | Buy |
9,025
+895
| +11% | +$48.1K | 0.01% | 1518 |
|
|
2019
Q3 | $433K | Buy |
8,130
+4,291
| +112% | +$220K | 0.01% | 1367 |
|
|
2019
Q2 | $196K | Buy |
+3,839
| New | +$179K | ﹤0.01% | 2060 |
|
|
2018
Q4 | – | Sell |
-4,155
| Closed | -$214K | – | 2335 |
|
|
2018
Q3 | $214K | Buy |
4,155
+4,153
| +207,650% | +$203K | 0.01% | 1378 |
|
|
2018
Q2 | $0 | Sell |
2
-24,095
| -100% | -$997K | ﹤0.01% | 2118 |
|
|
2018
Q1 | $855K | Sell |
24,097
-36,341
| -60% | -$1.42M | 0.05% | 512 |
|
|
2017
Q4 | $2.63M | Buy |
60,438
+35,403
| +141% | +$1.65M | 0.14% | 149 |
|
|
2017
Q3 | $1.31M | Buy |
25,035
+10,673
| +74% | +$595K | 0.07% | 309 |
|
|
2017
Q2 | $840K | Buy |
14,362
+3,162
| +28% | +$164K | 0.05% | 499 |
|
|
2017
Q1 | $514K | Buy |
+11,200
| New | +$557K | 0.04% | 620 |
|
|
2016
Q4 | – | Sell |
-1,524
| Closed | -$68K | – | 1931 |
|
|
2016
Q3 | $68K | Sell |
1,524
-3,469
| -69% | -$150K | ﹤0.01% | 1534 |
|
|
2016
Q2 | $190K | Buy |
+4,993
| New | +$219K | 0.01% | 1358 |
|
|
2016
Q1 | – | Sell |
-12,794
| Closed | -$621K | – | 1893 |
|
|
2015
Q4 | $621K | Buy |
12,794
+566
| +5% | +$25.2K | 0.04% | 712 |
|
|
2015
Q3 | $489K | Buy |
12,228
+3,398
| +38% | +$148K | 0.02% | 971 |
|
|
2015
Q2 | $354K | Sell |
8,830
-16,708
| -65% | -$576K | 0.02% | 1135 |
|
|
2015
Q1 | $836K | Buy |
25,538
+8,419
| +49% | +$233K | 0.04% | 664 |
|
|
2014
Q4 | $440K | Buy |
+17,119
| New | +$407K | 0.02% | 947 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Cubist Systematic Strategies's SYNH Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 14,020 shares — an estimated $591K sold.
Cubist Systematic Strategies first reported a position in SYNH in Q4 2014 and held it in 31 quarters. The position peaked at $11.7M in Q3 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Cubist Systematic Strategies reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 14,020 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $591K.
- Cubist Systematic Strategies first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 31 quarters.
- Cubist Systematic Strategies's Syneos Health, Inc. Class A Common Stock position peaked at $11.7M in Q3 2022.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.